ProfileGDS4718 / 216711_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 66% 62% 61% 64% 60% 61% 63% 64% 60% 59% 62% 65% 66% 63% 61% 59% 65% 60% 75% 57% 60% 58% 62% 61% 60% 63% 68% 66% 68% 59% 59% 63% 61% 65% 61% 59% 62% 64% 63% 63% 60% 60% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4105964
GSM549102patient 115, normal, homogenized [OPG study]6.573466
GSM549104patient 119, normal, homogenized [OPG study]6.2784762
GSM549108patient 138, normal, homogenized [OPG study]6.23361
GSM549119patient 077, normal, homogenized [OPG study]6.3679264
GSM549133patient 032, cancer, homogenized [OPG study]6.1148460
GSM549139patient 042, cancer, homogenized [OPG study]6.1881261
GSM549099patient 107, normal, homogenized [OPG study]6.3273863
GSM549109patient 139, normal, homogenized [OPG study]6.4051664
GSM549110patient 046, normal, homogenized [OPG study]6.149460
GSM549114patient 063, normal, homogenized [OPG study]6.0096259
GSM549122patient 082, normal, homogenized [OPG study]6.3067162
GSM549134patient 033, cancer, homogenized [OPG study]6.4311365
GSM549136patient 036, cancer, homogenized [OPG study]6.5447866
GSM549140patient 044, cancer, homogenized [OPG study]6.3284763
GSM549111patient 047, normal, homogenized [OPG study]6.2009761
GSM549113patient 057, normal, homogenized [OPG study]6.0018959
GSM549132patient 031, cancer, homogenized [OPG study]6.5147365
GSM549137patient 038, cancer, homogenized [OPG study]6.14460
GSM549142patient 047, cancer, homogenized [OPG study]7.2347175
GSM549100patient 110, normal, homogenized [OPG study]5.9450557
GSM549107patient 135, normal, homogenized [OPG study]6.0843360
GSM549115patient 068, normal, homogenized [OPG study]5.9319258
GSM549116patient 072, normal, homogenized [OPG study]6.2605262
GSM549120patient 078, normal, homogenized [OPG study]6.2206261
GSM549131patient 030, cancer, homogenized [OPG study]6.1051260
GSM549118patient 074, normal, homogenized [OPG study]6.333263
GSM549129patient 027, cancer, homogenized [OPG study]6.795768
GSM549123patient 088, normal, homogenized [OPG study]6.5483966
GSM549124patient 006, cancer, homogenized [OPG study]6.6496368
GSM549126patient 015, cancer, homogenized [OPG study]6.014959
GSM549128patient 025, cancer, homogenized [OPG study]6.0537159
GSM549103patient 117, normal, homogenized [OPG study]6.3212963
GSM549117patient 073, normal, homogenized [OPG study]6.1420161
GSM549138patient 041, cancer, homogenized [OPG study]6.4722265
GSM549141patient 045, cancer, homogenized [OPG study]6.2396461
GSM549130patient 028, cancer, homogenized [OPG study]6.0701359
GSM549101patient 111, normal, homogenized [OPG study]6.3059362
GSM549105patient 128, normal, homogenized [OPG study]6.4067364
GSM549106patient 134, normal, homogenized [OPG study]6.3609963
GSM549112patient 048, normal, homogenized [OPG study]6.3122763
GSM549125patient 011, cancer, homogenized [OPG study]6.154560
GSM549127patient 024, cancer, homogenized [OPG study]6.1703860
GSM549135patient 035, cancer, homogenized [OPG study]6.2399762